A new class of anticoagulant drugs on the horizon is taking takes fresh aim at one of cardiology’s toughest challenges: how to preventing blood clots that cause heart attacks and strokes, without leaving patients at risk of bleeding.
Wall Street Journal
A new class of anticoagulant drugs on the horizon is taking takes fresh aim at one of cardiology’s toughest challenges: how to preventing blood clots that cause heart attacks and strokes, without leaving patients at risk of bleeding.
https://www.wsj.com/health/pharma/blood-thinners-prevent-clots-bleeding-abd9fdae